Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$5.67 - $11.2 $11,612 - $22,937
2,048 Added 2.83%
74,395 $608,000
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $284,323 - $620,013
72,347 New
72,347 $420,000
Q2 2022

Aug 15, 2022

SELL
$4.02 - $10.43 $126,031 - $326,990
-31,351 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$8.43 - $20.9 $123,179 - $305,390
-14,612 Reduced 31.79%
31,351 $285,000
Q4 2021

Feb 10, 2022

SELL
$19.26 - $30.08 $332,446 - $519,210
-17,261 Reduced 27.3%
45,963 $940,000
Q3 2021

Nov 10, 2021

SELL
$24.86 - $35.02 $1.06 Million - $1.49 Million
-42,588 Reduced 40.25%
63,224 $1.62 Million
Q2 2021

Aug 11, 2021

SELL
$22.3 - $36.02 $1.05 Million - $1.7 Million
-47,071 Reduced 30.79%
105,812 $3.7 Million
Q1 2021

May 12, 2021

BUY
$26.38 - $51.15 $1.61 Million - $3.13 Million
61,214 Added 66.78%
152,883 $5.09 Million
Q4 2020

Feb 10, 2021

BUY
$10.5 - $28.5 $962,524 - $2.61 Million
91,669 New
91,669 $2.38 Million
Q3 2020

Nov 13, 2020

SELL
$3.61 - $9.87 $61,572 - $168,342
-17,056 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$4.6 - $5.57 $69,786 - $84,502
-15,171 Reduced 47.08%
17,056 $88,000
Q3 2019

Nov 12, 2019

SELL
$4.99 - $6.16 $888,135 - $1.1 Million
-177,983 Reduced 84.67%
32,227 $166,000
Q2 2019

Aug 09, 2019

SELL
$5.92 - $7.41 $21,252 - $26,601
-3,590 Reduced 1.68%
210,210 $1.27 Million
Q1 2019

May 15, 2019

SELL
$6.8 - $7.4 $668,494 - $727,479
-98,308 Reduced 31.5%
213,800 $1.55 Million
Q4 2018

Feb 14, 2019

SELL
$3.99 - $7.82 $551,497 - $1.08 Million
-138,220 Reduced 30.69%
312,108 $2.31 Million
Q3 2018

Nov 13, 2018

BUY
$3.52 - $5.55 $1.59 Million - $2.5 Million
450,328 New
450,328 $2.44 Million
Q4 2017

Feb 14, 2018

SELL
$2.59 - $5.44 $452,302 - $950,008
-174,634 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$3.2 - $5.57 $558,828 - $972,711
174,634
174,634 $917,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $407M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.